Core Viewpoint - The legal opinion letter confirms that the procedures for the 2024 annual general meeting of Shanghai Buke Automation Co., Ltd. comply with relevant laws and regulations, ensuring the legitimacy of the meeting and its resolutions [2][12]. Group 1: Meeting Procedures - The board of directors decided to hold the annual general meeting on May 16, 2025, during the ninth meeting of the fifth board on April 23, 2025 [2]. - The meeting notice was published on April 25, 2025, detailing the meeting's time, location, voting methods, and agenda [3]. - The meeting was conducted using a combination of on-site and online voting, with specific time slots for each voting method [4]. Group 2: Attendance and Qualifications - The meeting was convened by the board of directors, meeting legal and regulatory requirements [5]. - Eligible attendees included shareholders registered by May 12, 2025, and their authorized representatives, along with company directors, supervisors, and appointed lawyers [5]. - A total of 43 participants represented 60,980,377 shares, accounting for 72.5956% of the total voting shares [6]. Group 3: Agenda and Voting Results - The agenda included a proposal for the board to authorize stock issuance to specific targets [8]. - The voting results showed that 60,956,783 shares approved the proposals, representing 99.9967% of the votes cast [9][10]. - Among minority investors, 3,793,337 shares voted in favor, indicating a strong majority support [10][11]. Group 4: Conclusion - The legal opinion concludes that all aspects of the meeting, including procedures, qualifications, and voting results, are in compliance with applicable laws and the company's articles of association, rendering the resolutions valid [12].

关于 中农立华生物科技股份有限公司 法律意见书 北京市东城区金宝街 89 号金宝大厦 11 层邮编：100005 电话（Tel）：（86-10）66523388 传真（Fax）：（86-10）66523399 网址（Website）：www.junzejun.com 电子信箱（E-mail） ：jzj@junzejun.com 法律意见书 北京市君泽君律师事务所 关于 中农立华生物科技股份有限公司 法律意见书 致：中农立华生物科技股份有限公司 北京市君泽君律师事务所（以下简称"本所"）受中农立华生物科技股份有限 公司（以下简称"公司"）委托，指派本所律师出席公司 2024 年年度股东大会（以 下简称"本次股东大会"），就本次公司股东大会召集、召开程序、出席本次股东 大会人员的资格以及本次股东大会的表决程序、表决结果进行见证，并出具本法 律意见书。 为出具本法律意见书，本所律师特作出如下声明： 书出具之日前（含当日）已经发生或者存在的事实，履行了法定职责，遵循了勤 勉尽责和诚实信用原则，进行了相应的核查验证，保证本法律意见书所认定的事 实真实、准确、完整，所发表的结论性意见合法、准确，不存在虚假记载、误导 性陈 ...

Core Viewpoint - The legal opinion confirms that the procedures for convening and holding the 2024 annual general meeting of Beijing Borui Hongyuan Data Technology Co., Ltd. comply with relevant laws and regulations, ensuring the legitimacy and effectiveness of the meeting [2][24]. Meeting Procedures - The meeting was convened following a resolution from the company's board of directors [4][6]. - A notice regarding the meeting was published 20 days prior, detailing the time, location, attendees, and agenda [5]. - The meeting combined both in-person attendance and online voting [6]. Attendee Qualifications - The meeting was convened by the company's board of directors, meeting legal requirements [6]. - A total of 21 attendees represented 21,563,255 shares, accounting for 48.57% of the total voting shares [6][7]. - 16 small investors participated in the meeting, representing 3,350,662 shares, or 7.55% of the total voting shares [7]. Voting Procedures and Results - Voting was conducted through written ballots for in-person attendees and online voting for remote participants [8][24]. - The results showed that 21,570,355 shares voted in favor of the proposal, representing 99.7984% of the votes cast, while 43,562 shares opposed, accounting for 0.2016% [8][10]. - The voting results for small investors indicated that 3,307,100 shares supported the proposal, which is 98.6998% of their total voting shares [12][20]. Conclusion - The legal opinion concludes that all aspects of the meeting, including the convening procedures, attendee qualifications, voting procedures, and results, are in compliance with applicable laws and regulations, thus validating the meeting's legitimacy [24][25].

河南金通源律师事务所 法律意见 书 河南金通源律师事务所 关于 好想你健康食品股份有限公司 的 法律意见书 金律法字（2025）第 0515 号 二〇二五年五月十五日 河南金通源律师事务所 法律意见 书 书 __________________________________________________________________________________ 河南金通源律师事务所 关于好想你健康食品股份有限公司 金律法字（2025）第 0515 号 致：好想你健康食品股份有限公司 受好想你健康食品股份有限公司（以下简称"公司"）的委托，河南金通源律 师事务所（以下简称"本所"）指派张树才、胡中阳律师（以下简称"本所律师"） 对公司 2024 年度股东大会（以下简称"本次股东大会"）进行现场见证。 根据《中华人民共和国证券法》（以下简称"《证券法》"）、《中华人民共 和国公司法》（以下简称"《公司法》"）、《上市公司股东大会规则》（以下简 称"《股东大会规则》"）、《深圳证券交易所上市公司股东大会网络投票实施细 则》（以下简称"《网络投票实施细则》"）等法律、行政法规和规范性文件及 《好想你健康食品 ...

Financial Data and Key Metrics Changes - The company received approval for the financial accounts for the fiscal year ended December 31, 2024, indicating a successful completion of the financial reporting process [8][9]. Business Line Data and Key Metrics Changes - No specific data or metrics related to individual business lines were provided in the meeting [1][2]. Market Data and Key Metrics Changes - No specific market data or metrics were discussed during the meeting [1][2]. Company Strategy and Development Direction and Industry Competition - The meeting focused on the formal business of the annual general meeting, with resolutions proposed for the re-election of directors, indicating a stable governance structure [8][9]. Management's Comments on Operating Environment and Future Outlook - Management did not provide specific comments on the operating environment or future outlook during this meeting [1][2]. Other Important Information - The meeting was conducted in a virtual format to enhance inclusivity for shareholders [3][4]. - The inspector of election confirmed that more than 50% of shares were represented, constituting a quorum for the meeting [6]. Q&A Session All Questions and Answers - No questions or answers were recorded during the meeting [1][2].

Group 1 - The company held its 2024 annual performance briefing on May 14, 2025, via the "Panorama Roadshow" website, allowing for interactive communication with investors regarding its operational results and financial indicators [1][2][3] - Key executives, including the president and financial director, participated in the briefing to address investor inquiries [2] - The company expressed gratitude for the long-term support and attention from investors [3] Group 2 - The company’s board of directors convened a temporary meeting on May 12, 2025, to discuss and approve various proposals, including providing guarantees for its subsidiary [5][6] - The board approved a guarantee for its subsidiary, Guancheng Ruimin, amounting to 168 million yuan, with collateral provided by the company’s shares in Fudian Bank [6][12] - The board also agreed to hold the first temporary shareholders' meeting of 2025 on May 30, 2025, to review the guarantee proposal [8][19] Group 3 - The company has provided a total of 154.11 million yuan in guarantees, which represents 26.35% of its latest audited net assets [18] - If all proposed guarantees are executed, the total would exceed 311.19 million yuan, accounting for 53.21% of the company's latest audited net assets [18] - The company’s subsidiary, Guancheng Ruimin, has a debt-to-asset ratio exceeding 70%, necessitating careful monitoring of financial risks associated with the guarantees [12][16]

证券代码：603002 证券简称：宏昌电子 公告编号：2025-024 宏昌电子材料股份有限公司 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： ? 本次会议是否有否决议案：无 一、 会议召开和出席情况 份总数的比例（%） 54.4017 (四) 表决方式是否符合《公司法》及《公司章程》的规定，大会主持情况等。 本次股东大会采取现场投票与网络投票相结合的方式召开。本次股东大会由 公司董事会召集，董事长林瑞荣先生主持，会议的召集和召开程序、出席会议人 员的资格、会议的表决方式和程序均符合相关法律、法规及《公司章程》等的有 关规定。 (五) 公司董事、监事和董事会秘书的出席情况 二、 议案审议情况 (一)非累积投票议案 审议结果：通过 (一) 股东大会召开的时间：2025 年 5 月 14 日 (二) 股东大会召开的地点：广州市黄埔区开创大道 728 号保利中创孵化器 3 号 楼 212 室公司会议室 (三) 出席会议的普通股股东和恢复表决权的优先股股东及其持有股份情况： 表决情况： | 股东类型 | 同意 | | ...

Financial Data and Key Metrics Changes - The meeting confirmed the election of 10 nominees to the Board of Directors and the ratification of Ernst and Young LLP as the independent public accountants for the fiscal year ending December 31, 2025 [7][8] - The compensation of named executive officers was approved during the meeting [8] Business Line Data and Key Metrics Changes - No specific business line data or key metrics were discussed during the meeting [9][10] Market Data and Key Metrics Changes - No specific market data or key metrics were provided during the meeting [9][10] Company Strategy and Development Direction and Industry Competition - The company did not provide detailed comments on its strategy or competitive landscape during the meeting [9][10] Management's Comments on Operating Environment and Future Outlook - Management did not offer insights into the operating environment or future outlook during the meeting [9][10] Other Important Information - The meeting was conducted virtually, and participants were reminded to follow the rules of conduct [4][5] - The meeting was attended by various board members and representatives from Ernst and Young LLP [3][5] Q&A Session All Questions and Answers Question: Were there any questions from stockholders? - No questions were received from stockholders during the Q&A session [9]

Core Viewpoint - The legal opinion letter confirms that the 2024 annual general meeting of shareholders for Luoxin Pharmaceutical Group Co., Ltd. was convened and conducted in accordance with relevant laws, regulations, and the company's articles of association [1][2][3]. Group 1: Meeting Procedures - The meeting was convened on May 12, 2025, at the designated location, and the actual time, place, and manner of the meeting were consistent with the prior announcements [4][6]. - The legal opinion asserts that the procedures for convening and holding the meeting complied with legal and regulatory requirements [3][4]. Group 2: Attendance and Qualifications - A total of 170 shareholders attended the meeting, representing 242,426,486 shares, which is 22.8368% of the total voting shares [5][6]. - The qualifications of the attendees, including institutional and individual shareholders, were verified and found to be in compliance with legal requirements [5][6]. Group 3: Voting Procedures and Results - The voting process was conducted through a combination of on-site and online voting, with the results being verified by the legal representatives present [6][8]. - The voting results showed that the majority of proposals were approved, with significant support from shareholders, including 99.8776% approval for one of the key resolutions [8][12].

力源信息 2024 年年度股东大会法 律意见书 关于武汉力源信息技术股份有限公司 法 律 意 见 书 华隽律师事务所 HUA JUN & CO. 地址：武汉市建设大道 847 号瑞通广场 B 座 23 楼 邮编：430015 电话： （027）59407398 传真： （027）59407397 Add: 23th floors, Sutie B, Ruitong Plaza, 847# jianshe Avenue, Wuhan, P. R. China P.C: 430015 Tel: （027）59407398 Fax: （027）59407397 Http: //www.hjlaw.net 力源信息 2024 年年度股东大会法律意见书 关于武汉力源信息技术股份有限公司 法 律 意 见 书 致：武汉力源信息技术股份有限公司 湖北华隽律师事务所（以下简称"本所" ）接受武汉力源信息技术股份有限公司（以下 简称"公司"）的委托，指派本所律师姚远、王娟出席公司 2024 年年度股东大会（以下简称 "本次股东大会"），依据《中华人民共和国证券法》 （以下简称"《证券法》"）、 《中华人民共 和国公司法》 （以下 ...